Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach

por Hu, Xiao, Liu, Xikui, Morgan, Rodney, Moisan, Jacques, Hao, Ling-Yang, Wang, Yahong, Sanchez, Brian, Lesch, Charles, Bousley, Dick, Taylor, Clark, Aicher, Thomas, Toogood, Peter, Zou, Weiping, Glick, Gary, Carter, Laura
Publicado en J Immunother Cancer (2014)

Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease

por Glick, Gary D., Rossignol, Rodrigue, Lyssiotis, Costas A., Wahl, Daniel, Lesch, Charles, Sanchez, Brian, Liu, Xikui, Hao, Ling-Yang, Taylor, Clarke, Hurd, Alexander, Ferrara, James L. M., Tkachev, Victor, Byersdorfer, Craig A., Boros, Laszlo, Opipari, Anthony W.
Publicado 2014

RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity

por Hu, Xiao, Moisan, Jacques, Majchrzak, Kinga, Lesch, Chuck, Wang, Yahong, Sanchez, Brian, Liu, Xikui, Morgan, Rodney, Mertz, David, Bousley, Dick, van Huis, Chad, Skalitzky, Don, Taylor, Clarke, Aicher, Thomas, Toogood, Peter, Zou, Weiping, Glick, Gary, Paulos, Chrystal, Carter, Laura
Publicado en J Immunother Cancer (2015)

Inhibiting Oxidative Phosphorylation in Vivo Restrains T(H)17 Effector Responses and Ameliorates Murine Colitis()

por Franchi, Luigi, Monteleone, Ivan, Hao, Ling-Yang, Spahr, Mark, Zhao, Wenpu, Liu, Xikui, Demock, Kellie, Kulkarni, Aditi, Lesch, Chuck A., Sanchez, Brian, Carter, Laura, Marafini, Irene, Hu, Xiao, Mashadova, Oksana, Yuan, Min, Asara, John M., Singh, Harinder, Lyssiotis, Costas A., Monteleone, Giovanni, Opipari, Anthony W., Glick, Gary D.
Publicado en J Immunol (2017)